UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 67

Sortiert nach

T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant

Nature medicine, 2019-07, Vol.25 (7), p.1064-1072

2019

Link zum Volltext

Verfügbarkeit prüfen

Vaccination Alters the Balance between Protective Immunity, Exhaustion, Escape, and Death in Chronic Infections

Journal of Virology, 2011-06, Vol.85 (11), p.5565-5570

2011

Link zum Volltext

Verfügbarkeit prüfen

Enhanced T-cell immunity to osteosarcoma through antibody blockade of PD-1/PD-L1 interactions

Journal of immunotherapy (1997), 2015-04, Vol.38 (3), p.96

2015

Link zum Volltext

Verfügbarkeit prüfen

The Anticancer Potential of T Cell Receptor-Engineered T Cells

Trends in cancer, 2021-01, Vol.7 (1), p.48-56

2021

Link zum Volltext

Verfügbarkeit prüfen

Detection of engineered T cells in FFPE tissue by multiplex in situ hybridization and immunohistochemistry

Journal of immunological methods, 2021-05, Vol.492, p.112955-112955, Article 112955

2021

Link zum Volltext

Verfügbarkeit prüfen

Abrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivo

The Journal of immunology (1950), 2012-08, Vol.189 (4), p.1812-1825

2012

Link zum Volltext

Verfügbarkeit prüfen

Retinaldehyde dehydrogenase 2 as a molecular adjuvant for enhancement of mucosal immunity during DNA vaccination

Vaccine, 2016-11, Vol.34 (46), p.5629-5635

2016

Link zum Volltext

Verfügbarkeit prüfen

Interaction between unrelated viruses during in vivo co-infection to limit pathology and immunity

Virology (New York, N.Y.), 2015-10, Vol.484, p.153-162

2015

Link zum Volltext

Verfügbarkeit prüfen

Combating chronic T-cell exhaustion

Immunotherapy, 2012-06, Vol.4 (6), p.557-560

2012

Link zum Volltext

Verfügbarkeit prüfen

The anti-cancer potential of T cell receptor-engineered T cells

Trends in cancer, 2020-09, Vol.7 (1), p.48-56

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3569: Humanized mouse model of MAGE-A1-targeted anti-melanoma T cell therapy

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3569-3569

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3567: Novel approaches to high-affinity TCR isolation for clinical translation enabled by single cell RNA sequencing

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3567-3567

2018

Link zum Volltext

Verfügbarkeit prüfen

Abrogation of SHP-1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivo

The Journal of immunology (1950), 2012-07, Vol.189 (4), p.1812-1825

2012

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of T cell immunity to osteosarcoma through modulation of PD-1/PD-L1 interactions

Journal for immunotherapy of cancer, 2013-11, Vol.1 (S1), p.P162-P162, Article P162

2013

Link zum Volltext

Verfügbarkeit prüfen

The Relations Among Childhood Maltreatment and Later Intimate Partner Violence Victimization With and Without a Weapon in a Sample of Pregnant Black Individuals

Journal of interpersonal violence, 2024-04, p.8862605241245386-8862605241245386

2024

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease

Transplantation, 2011-03, Vol.91 (6), p.672

2011

Link zum Volltext

Verfügbarkeit prüfen

Merkel polyomavirus specific transgenic T cell receptor therapy in PD-1 inhibitor refractory Merkel cell carcinoma

Journal of investigative dermatology, 2022-10, Vol.142 (10), p.2840

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase 1 study of the antibody‐drug conjugate brentuximab vedotin with re‐induction chemotherapy in patients with CD30‐expressing relapsed/refractory acute myeloid leukemia

Cancer, 2020-03, Vol.126 (6), p.1264-1273

2020

Link zum Volltext

Verfügbarkeit prüfen

Mechanism of T cell mediated hemorrhagic disease during LCMV infection

The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.94-94.16

2020

Link zum Volltext

Verfügbarkeit prüfen

Attamage-A1: Phase I/II study of autologous CD8+ and CD4+ transgenic t cells expressing high affinity MAGE-A1-specific T-cell receptor (TCR) combined with anti-PD(L)1 in patients with metastatic MAGE-A1 expressing cancer

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.TPS592-TPS592

2022

Link zum Volltext

Verfügbarkeit prüfen

Fax referrals, academic detailing, and tobacco quitline use: a randomized trial

American journal of preventive medicine, 2012-01, Vol.42 (1), p.21-28

2012

Link zum Volltext

Verfügbarkeit prüfen

192 Pooled T cell receptor screening (POTS) provides unbiased, high-throughput method for TCR discovery

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A204-A204

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of Ixazomib with Conventional Chemotherapy in the Treatment of Acute Myeloid Leukemia in Older Adults

Blood, 2022-11, Vol.140 (Supplement 1), p.3309-3311

2022

Link zum Volltext

Verfügbarkeit prüfen

Early Relationships of a Low‐Energy Diet With Symptoms of Fibromyalgia

ACR open rheumatology, 2022-05, Vol.4 (5), p.464-469

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(66)
Dissertationen
(1)

Sprache

Englisch
(67)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant

Vaccination Alters the Balance between Protective Immunity, Exhaustion, Escape, and Death in Chronic Infections

Enhanced T-cell immunity to osteosarcoma through antibody blockade of PD-1/PD-L1 interactions

The Anticancer Potential of T Cell Receptor-Engineered T Cells

Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency

Detection of engineered T cells in FFPE tissue by multiplex in situ hybridization and immunohistochemistry

Abrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivo

Retinaldehyde dehydrogenase 2 as a molecular adjuvant for enhancement of mucosal immunity during DNA vaccination

Interaction between unrelated viruses during in vivo co-infection to limit pathology and immunity

Combating chronic T-cell exhaustion

The anti-cancer potential of T cell receptor-engineered T cells

Abstract 3569: Humanized mouse model of MAGE-A1-targeted anti-melanoma T cell therapy

Abstract 3567: Novel approaches to high-affinity TCR isolation for clinical translation enabled by single cell RNA sequencing

Abrogation of SHP-1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivo

Enhancement of T cell immunity to osteosarcoma through modulation of PD-1/PD-L1 interactions

The Relations Among Childhood Maltreatment and Later Intimate Partner Violence Victimization With and Without a Weapon in a Sample of Pregnant Black Individuals

Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease

Merkel polyomavirus specific transgenic T cell receptor therapy in PD-1 inhibitor refractory Merkel cell carcinoma

A phase 1 study of the antibody‐drug conjugate brentuximab vedotin with re‐induction chemotherapy in patients with CD30‐expressing relapsed/refractory acute myeloid leukemia

Mechanism of T cell mediated hemorrhagic disease during LCMV infection

Attamage-A1: Phase I/II study of autologous CD8+ and CD4+ transgenic t cells expressing high affinity MAGE-A1-specific T-cell receptor (TCR) combined with anti-PD(L)1 in patients with metastatic MAGE-A1 expressing cancer

Fax referrals, academic detailing, and tobacco quitline use: a randomized trial

192 Pooled T cell receptor screening (POTS) provides unbiased, high-throughput method for TCR discovery

Phase I Study of Ixazomib with Conventional Chemotherapy in the Treatment of Acute Myeloid Leukemia in Older Adults

Early Relationships of a Low‐Energy Diet With Symptoms of Fibromyalgia

Suchergebnisse filtern